Edition:
United Kingdom

Kaisa Group Holdings Ltd (1638.HK)

1638.HK on Hong Kong Stock

4.22HKD
23 Feb 2018
Change (% chg)

HK$0.08 (+1.93%)
Prev Close
HK$4.14
Open
HK$4.19
Day's High
HK$4.25
Day's Low
HK$4.17
Volume
4,817,426
Avg. Vol
24,060,319
52-wk High
HK$6.91
52-wk Low
HK$2.10

Select another date:

Wed, Feb 14 2018

BRIEF-Kaisa Group Holdings Says Jan Contracted Sales Was Up 3.8 Pct

* JAN CONTRACTED SALES RMB2,966 MILLION, UP 3.8% Source text for Eikon: Further company coverage:

BRIEF-Kaisa Group Holdings' Yu Jianqing Resigns As An Executive Director

* MAI FAN, EXECUTIVE DIRECTOR OF CO, APPOINTED AS AUTHORISED REPRESENTATIVE OF CO Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

BRIEF-Kaisa Group Holdings ‍Posts Contracted Sales Of About Rmb5,072 Mln In Dec

* ‍CONTRACTED SALES OF APPROXIMATELY RMB5,072 MILLION IN DEC 2017​ Source text for Eikon: Further company coverage:

BRIEF-Kaisa Group Holdings Posts Nov Total Contracted Sales Of About RMB5.10 Bln​

* ‍RECORDED TOTAL CONTRACTED SALES OF APPROXIMATELY RMB5,103 MILLION IN NOVEMBER​

UPDATE 1-China developer Kaisa makes $332 mln investment in biopharma firm

* Developer was China's first to default on offshore bonds (Adds executive comment, Kaisa context, share prices)

BRIEF-Kaisa Group Says Unit To Buy 18.57 Pct Interest In Zhenxing Biopharmaceutical & Chemical Co​

* ‍ANNOUNCES ACQUISITION OF AN APPROXIMATELY 18.57% INTEREST IN ZHENXING BIOPHARMACEUTICAL & CHEMICAL CO​

China's Kaisa to buy 19 pct Zhenxing Bio stake for $332 mln

HONG KONG, Nov 29 Kaisa Group Holdings Ltd said on Wednesday it planned to buy a 2.19 billion yuan ($332 million) stake in blood products producer Zhenxing Biopharmaceutical & Chemical Co Ltd as the Chinese developer diversifies and expands its footprint in the healthcare industry.

BRIEF-Kaisa Group Holdings posts Oct total contracted sales of RMB4,355 mln

* Group recorded total contracted sales of RMB4,355 million in October 2017​ Source text for Eikon: Further company coverage:

BRIEF-Kaisa Group Holdings announces issue of additional senior notes

* Eentered into subscription agreements for US$30 million 7.25% senior notes due 2020 and US$100 million 7.875% senior notes due 2021

BRIEF-Kaisa Group Holdings updates on total contracted sales for September ​

* ‍Group recorded total contracted sales of about RMB3,211 million in September ​ Source text for Eikon: Further company coverage:

Select another date: